December 16, 2014
FDA, Joint Commission cite safety concerns with power morcellation
Reports about problems associated with power morcellation in gynecologic surgery led to safety warnings in November 2014 by the Food and Drug Administration (FDA) and the Joint Commission.
Free Daily News
- 2026 ICD-10 updates bring hundreds of new codes, new complexity
- Standardized pathways cut costs, hospital days in pediatric surgery without raising complication rates
- UC Davis secures $2M to study bone health in prostate cancer, prevent post-injury arthritis
- Artificial disc replacement proves safe, efficient, cost-saving in outpatient spine surgery
- Hospital-affiliated doctors drive highest costs by avoiding lower-cost sites
- Imposter syndrome widespread among surgical trainees, disproportionately affects women
- Global nursing workforce grows but inequities jeopardize health progress
- Largest US healthcare fraud case reveals billions in false Medicare, Medicaid claims and vast schemes nationwide
- Hospital margins improve as outpatient revenue accelerates, but costs loom
- Breast cancer surgery delays tied to higher upstaging, faster tumor growth
© Access Intelligence, LLC. All rights reserved. |
Privacy Policy |
Cookie Settings |
Diversity, Equity, Inclusion & Belonging |
Accessibility Statement